MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01932cam a2200277 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
9780429016769 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
210328t2019 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780429016769 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781138580589 |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Carlton, Richard M. |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Type 2 diabetes :cardiovascular and related complications and evidence-based complementary treatments |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Boca Raton : |
| Name of publisher, distributor, etc. |
CRC Press., |
| Date of publication, distribution, etc. |
2019 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (xxvii, 481 pages), illustrations (black and white, and colour). |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Also issued in print: 2019. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Approximately 29 million Americans are diagnosed with Type 2 diabetes annually. Of that number, only about 36% (10.44 million diabetes sufferers) achieve satisfactory medical outcomes and would need additional help - rarely available - to reliably control their glucose levels. Contrary to popular belief, although anti-diabetic medications can lower sugar levels, nevertheless they have a poor performance track record because inflammation in the blood vessels persists. This book details recent scientific findings that cardiovascular, kidney, vision, peripheral nervous system, and other body damage caused by chronic high levels of blood sugar (hyperglycemia) in Type 2 diabetes is actually due to excessive generation of unopposed free radicals and reactive oxygen species (ROS). |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
online resource |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Includes bibliographical references and index. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Non-insulin-dependent diabetes--Complications--Alternative treatment. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Heart--Diseases--Alternative treatment. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Evidence-based medicine. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Kortext. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Fried, Robert |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://app.kortext.com/Shibboleth.sso/Login?entityID=https://idp.eng.nhs.uk/openathens&target=https://app.kortext.com/borrow/316025">https://app.kortext.com/Shibboleth.sso/Login?entityID=https://idp.eng.nhs.uk/openathens&target=https://app.kortext.com/borrow/316025</a> |
| Link text |
[OpenAthens account required for access.] |